Securing market access requires more than just clinical data. You need to prove that your innovation won’t break the bank. We develop clear, powerful analyses that show how your technology impacts the bottom line, helping you get a “yes” from budget holders.

• Budget Impact Analysis: This analysis helps you answer the critical question: “Can we afford this?” We model the financial impact of your technology on a specific budget, like the NHS or Health Insurance Plan, providing you with the evidence to prove its affordability and make a strong case for adoption.
• Cost-Effectiveness Analysis: This model goes beyond cost to prove the long-term value of your innovation. We compare your technology to current care, demonstrating its incremental health benefits in relation to costs. This is an essential component for any Health Technology Assessment (HTA) submission.
• Cost-Consequences Analysis: This is a powerful alternative when you need to strengthen a funding application. We model and compare costs against a range of outcomes, such as monetary savings or specific health improvements, in a clear, non-technical format that resonates with funders.
• Visual Communication Tools: Your data is only as good as your ability to communicate it. We design user-friendly visual tools that translate complex health economic evaluations into clear, compelling arguments that prove your innovation’s value to potential customers and budget holders.

Related Case Studies

Regulatory bodies and payers like NICE require robust evidence to approve new technologies. We help you navigate this complex process by building a rock-solid evidence base that accelerates your path to approval.

• HTA Submission & Critical Appraisal: We prepare comprehensive HTA submission documents that integrate evidence synthesis, literature reviews, and economic modeling. Our team can also critically appraise your existing submissions and research to identify potential risks and provide actionable recommendations.
• Systematic and Pragmatic Literature Reviews: We perform systematic and pragmatic literature reviews that form the cornerstone of your evidence base. Whether you need the gold-standard review for an HTA submission or a streamlined version to inform an early-stage model, we find the right data to support your arguments.
• Evidence Synthesis & Meta Analysis: We use advanced statistical methods to synthesise the results of existing studies. Depending on the quality of data available, a meta-analysis can reduce costs by avoiding unnecessary clinical trials.
• Scoping Reviews: Before you invest in a full-scale review, we can map the entire landscape of published evidence. This helps you identify key concepts and research gaps, ensuring your future research is targeted and effective.

Economic models tell you what should happen. Outcomes research tells you what actually does. We design and deliver studies that evaluate how health technologies perform in real NHS settings — generating the evidence base for continued adoption, spread, and commissioning decisions.

• Outcomes study design: Observational, pragmatic, and before/after evaluation frameworks suited to NHS contexts, aligned with NICE real-world evidence standards.
• Real-world evidence studies: Analysis of routine NHS data and clinical datasets to generate post-market evidence supporting ongoing access, publication, and differentiation.
• Comparative effectiveness: Head-to-head comparisons of technologies in real-world settings, informing procurement and disinvestment decisions with robust data.
• Value dossiers: Post-market evidence packages combining real-world outcomes, safety data, and economic impact — ready for payer or NHS Trust review

Many health technologies deliver their greatest value through efficiency gains, staff time savings, and reduced administrative burden — not direct clinical outcomes. We help you measure and communicate these benefits in terms that resonate with NHS operational leads, digital transformation teams, and CFOs.

• Workforce & time-savings modelling: Quantify staff time, grade-mix, and task-reallocation benefits of automation and workflow tools — translated into financial terms for Trust finance teams.
• Return on investment analysis: ROI frameworks capturing avoided costs, reduced length of stay, avoided referrals, and opportunity costs — structured for NHS business case templates.
• Non-clinical value frameworks: Evidence frameworks for AI-assisted tools, scheduling, remote monitoring, and decision support — making the operational case to the people holding budgets.